Tipelukast
- Generic Name
- Tipelukast
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C29H38O7S
- CAS Number
- 125961-82-2
- Unique Ingredient Identifier
- 08379P260O
- Background
Tipelukast is under investigation for the treatment of IPF and Idiopathic pulmonary fibrosis.
- Associated Conditions
- -
- Associated Therapies
- -
Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-21
- Last Posted Date
- 2022-04-27
- Lead Sponsor
- MediciNova
- Target Recruit Count
- 15
- Registration Number
- NCT02503657
- Locations
- 🇺🇸
Penn State University College of Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath